PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-2.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Interest & Investment Income (2013 - 2026)

Updated

PharmaCyte Biotech (PMCB) posted Interest & Investment Income of $166,278 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 23.7% from $217,793 a year earlier but up 111.8% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Interest & Investment Income (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jul 31, 2026, Interest & Investment Income at PharmaCyte Biotech was $681,836, down 37.2% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $733,351, down 48.2% from FY2025.

  • Annual Interest & Investment Income shows a four-year compound annual growth rate of 46.9% (FY2022 to FY2026).
  • In prior fiscal years, PharmaCyte Biotech's Interest & Investment Income was $1.42 million in FY2025 (-58.4%), $3.4 million in FY2024 (+75.4%), $1.94 million in FY2023 and $157,645 in FY2022.
  • Quarterly Interest & Investment Income has run from a low of $25,619 in fiscal Q2 2022 to a high of $894,181 in fiscal Q2 2024 over five years.
  • On a year-over-year basis, Interest & Investment Income has declined in each of the last nine quarters, with an average decline of 50.4% over the last eight quarters.
  • The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q4 2023, with growth of 735.1%; the weakest was fiscal Q3 2025, with a decline of 71.0%.
  • According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $78,503 (Q4 2026), $230,668 (Q3 2026) and $206,387 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 PharmaCyte Biotech 4.29 Mn 4.29 Mn - 166,278.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 166,278.00
Apr 30, 2026 78,503.00
Jan 31, 2026 230,668.00
Oct 31, 2025 206,387.00
Jul 31, 2025 217,793.00
Apr 30, 2025 229,875.00
Jan 31, 2025 255,692.00
Oct 31, 2024 382,562.00
Jul 31, 2024 547,432.00
Apr 30, 2024 747,098.00
Jan 31, 2024 881,662.00
Oct 31, 2023 894,181.00
Jul 31, 2023 875,878.00
Apr 30, 2023 722,937.00
Jan 31, 2023 635,889.00
Oct 31, 2022 439,171.00
Jul 31, 2022 139,502.00
Apr 30, 2022 86,567.00
Jan 31, 2022 45,459.00
Oct 31, 2021 25,619.00
API Access

PharmaCyte Biotech Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PMCB&period=max&api_key=YOUR_API_KEY